Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Low Risk Placebo	433
Overall Study	STARTED	High Risk Placebo	1,516
Overall Study	STARTED	High Risk Pioglitazone	1,545
Overall Study	Treated	Low Risk Placebo	427
Overall Study	Treated	High Risk Placebo	1,507
Overall Study	Treated	High Risk Pioglitazone	1,531
Overall Study	COMPLETED	Low Risk Placebo	4
Overall Study	COMPLETED	High Risk Placebo	40
Overall Study	COMPLETED	High Risk Pioglitazone	39
Overall Study	NOT COMPLETED	Low Risk Placebo	429
Overall Study	NOT COMPLETED	High Risk Placebo	1,476
Overall Study	NOT COMPLETED	High Risk Pioglitazone	1,506

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01931566/flow